开立医疗收盘上涨1.11%，滚动市盈率257.66倍，总市值129.55亿元

Group 1 - The core viewpoint of the articles highlights the performance and market position of Kaili Medical, which has a high PE ratio of 257.66, significantly above the industry average of 49.12 [1][2] - As of June 24, Kaili Medical's market capitalization stands at 12.955 billion yuan, with a recent stock price increase of 1.11% [1] - The company has seen a net inflow of 9.6875 million yuan in main funds on June 24, indicating a positive trend in capital flow over the past five days, totaling 10.4031 million yuan [1] Group 2 - Kaili Medical specializes in the research, development, production, and sales of medical diagnostic and treatment equipment, with a strong focus on ultrasound diagnostic devices and minimally invasive surgical products [1] - The company has over 20 years of experience in the ultrasound industry and is recognized as a high-tech enterprise, holding leading positions in several core technologies within the domestic market [1] - In the latest quarterly report for Q1 2025, Kaili Medical reported a revenue of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit of 8.0746 million yuan, down 91.94% year-on-year, with a gross margin of 63.19% [1]